120 pending office actions • 55 clients
| App # | Title | Client | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|---|
| 19372053 | Untitled | The Regents of the University of California | BRAZIN, JACQUELINE | 1798 | Non-Final OA | |
| 19372025 | Untitled | The Regents of the University of California | BRAZIN, JACQUELINE | 1798 | Non-Final OA | |
| 19349768 | MrgprX2 Antagonists for the Treatment of Inflammatory Disorders | Dermira, Inc. | WELLS, LAUREN QUINLAN | 1622 | Non-Final OA | Oct 03, 2025 |
| 19083310 | Method of Contextual Speech Decoding From the Brain | The Regents of the University of California | SHAH, JAY B | 3791 | Non-Final OA | Mar 18, 2025 |
| 19054584 | Linear DNA with Enhanced Resistance Against Exonucleases | 4Basebio UK Ltd. | DACE DENITO, ALEXANDRA GERALDINE | 1636 | Non-Final OA | Feb 14, 2025 |
| 18863312 | Nanoparticles for Delivery of Nucleic Acid Cargos | 4Basebio UK Ltd. | SCHLIENTZ, LEAH H | 1618 | Non-Final OA | Nov 05, 2024 |
| 18842751 | Resistive Switching Devices and Methods for their Manufacture and Operation | Cambridge Enterprise Limited | HIDALGO, FERNANDO N | 2827 | Non-Final OA | Aug 29, 2024 |
| 18728983 | Recombinant Cell Line Expressing Membrane Proteins and Vesicles Prepared Therefrom | Exocure Sweden AB | GULLEDGE, BRIAN M | 1699 | Non-Final OA | Jul 15, 2024 |
| 18772038 | NOVEL PEA PROTEIN ISOLATE COMPOSITION AND PROCESS FOR PRODUCTION THEREOF | Louis Dreyfus Company Plant Proteins LLC | MERRIAM, ANDREW E | 1791 | Non-Final OA | Jul 12, 2024 |
| 18672931 | Rust Resistance Gene | Commonwealth Scientific And Industrial Research Organisation | IBRAHIM, MEDINA AHMED | 1662 | Non-Final OA | May 23, 2024 |
| 18658264 | Methods for Representing Data Analysis and Systems for Same | The Regents of the University of California | SILVERMAN, SETH ADAM | 2172 | Non-Final OA | May 08, 2024 |
| 18702756 | Wearable Non-Invasive Central Nervous System Neuromodulator and Methods for Using Same | Spinex Inc. | KOWALKOWSKI, FIONA MARGARET | 3792 | Non-Final OA | Apr 18, 2024 |
| 18702725 | Collimatorless Combined Compton and Proximity Imaging Technology | The Regents of the University of California | KIKNADZE, IRAKLI | 2884 | Final Rejection | Apr 18, 2024 |
| 18609816 | SCREENING FOR PHARMACEUTICAL COMPOUNDS FOR IMPROVING MITOCHONDRIAL FUNCTION | Centaurus Therapeutics | AFREMOVA, VERA | 1653 | Non-Final OA | Mar 19, 2024 |
| 18605632 | Gas Exchange Composite Membranes and Methods of Use Thereof | The Regents of the University of California | DEAK, LESLIE R | 3799 | Non-Final OA | Mar 14, 2024 |
| 18688602 | STEROL THERAPY | Jena University Hospital | SHTERENGARTS, SAMANTHA L | 1623 | Non-Final OA | Mar 01, 2024 |
| 18294487 | PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATING HYPERHIDROSIS | Wayne Stephen Andrews | FAY, ZOHREH ALEMZADEH | 1617 | Non-Final OA | Feb 01, 2024 |
| 18418050 | MULTI-CBV VACCINE FOR PREVENTING OR TREATING TYPE I DIABETES | Vactech OY | CHEN, STACY BROWN | 1672 | Non-Final OA | Jan 19, 2024 |
| 18580417 | Methods and Model Systems for Assessing Therapeutic Properties of Candidate Agents and Related Computer Readable Media and Systems | The Regents of the University of California | JONES, CHRISTINE MICHELLE | 1682 | Non-Final OA | Jan 18, 2024 |
| 18578617 | Compounds for Modulating Epithelial 15-(S)-Lipoxygenase-2 and Methods of Use for Same | The Regents of the University of California | KUCKLA, ANNA GRACE | 1626 | Non-Final OA | Jan 11, 2024 |
| 18544232 | Methods and Systems for Detecting Biological Components | The Regents of the University of California | HORLICK, KENNETH R | 1681 | Non-Final OA | Dec 18, 2023 |
| 18520057 | E1E2 HCV VACCINES AND METHODS OF USE | The Governors of the University of Alberta | ZOU, NIANXIANG | 1671 | Non-Final OA | Nov 27, 2023 |
| 18563357 | HETEROCYCLIC COMPOUNDS AS KRAS INHIBITOR, AND PREPARATION THEREFOR AND USE THEREOF IN TREATMENT | Shanghai Kechow Pharma, Inc. | SAEED, KAMAL A | 1626 | Non-Final OA | Nov 21, 2023 |
| 18561981 | Methods And Devices For Real-Time Word And Speech Decoding From Neural Activity | The Regents of the University of California | PADDA, ARI SINGH KANE | 3791 | Non-Final OA | Nov 17, 2023 |
| 18389382 | SPECTROSCOPIC METHODS, REAGENTS AND SYSTEMS TO DETECT, IDENTIFY, AND CHARACTERIZE BACTERIA FOR ANTIMICROBIAL SUSCEPTIBLITY | Spectral Platforms, Inc. | UNDERWOOD, JARREAS C | 2877 | Non-Final OA | Nov 14, 2023 |
| 18289214 | COMPOUNDS FOR MODULATING PLATELET-TYPE 12-(S)-LIPOXYGENASE AND METHODS OF USE FOR SAME | The Regents of the University of California | YOO, SUN JAE | 1621 | Non-Final OA | Nov 01, 2023 |
| 18288793 | COMPOUNDS AND THEIR USES AS CD38 INHIBITORS | Nanjing Immunophage Biotech Co., Ltd. | LEE, ANDREW P | 1691 | Non-Final OA | Oct 27, 2023 |
| 18288711 | HETEROARYL COMPOUNDS USEFUL IN THE TREATMENT OF COGNITIVE DISORDERS | UNIVERSITY COLLEGE CARDIFF CONSULTANTS LTD | HABTE, KAHSAY | 1624 | Non-Final OA | Oct 27, 2023 |
| 18384286 | ANTIFUNGAL COMPOSITIONS AND METHODS FOR THEIR USE | Texas Crop Science, Inc. | HIRT, ERIN E | 1616 | Non-Final OA | Oct 26, 2023 |
| 18384266 | WATER DISPERSIBLE GRANULE ACYLHYDRAZONE APYRASE INHIBITOR FORMULATION | Texas Crop Science, Inc. | VIGIL, TORIANA NICHOLE | 1612 | Non-Final OA | Oct 26, 2023 |
| 18382419 | SUSPENSION CONCENTRATE ACYLHYDRAZONE APYRASE INHIBITOR FORMULATION | Texas Crop Science, Inc. | ARMSTRONG, SUSANNAH SIPPLE | 1616 | Non-Final OA | Oct 20, 2023 |
| 18556227 | A Triple Co-Culture System for Drug Screening of Patient-Derived Cancer Cells and Methods of Use | CONSEJO NACIONAL DE INVESTIGACIONES CIENTÍFICAS Y TÉCNICAS | CLARKE, TRENT R | 1651 | Non-Final OA | Oct 19, 2023 |
| 18285814 | Thermally Stable Vaccine Formulations Utilising Metal Organic Framework (MOF) Shells | Commonwealth Scientific And Industrial Research Organisation | PARK, HAEJIN S | 1614 | Non-Final OA | Oct 05, 2023 |
| 18551553 | Pharmaceutical Combinations for Treating Cancer | BOEHRINGER INGELHEIM INTERNATIONAL GMBH | DRISCOLL, MAUREEN VARINA | 1644 | Non-Final OA | Sep 20, 2023 |
| 18551502 | Pharmaceutical Combinations for Treating Cancer | T3 Pharmaceuticals AG | BUTTICE, AUDREY L | 1647 | Non-Final OA | Sep 20, 2023 |
| 18282507 | ANTI-VACCINIA VIRUS ANTIGEN ANTIBODIES AND RELATED COMPOSITIONS AND METHODS | UVIC INDUSTRY PARTNERSHIPS INC. | HADDAD, MAHER M | 1641 | Non-Final OA | Sep 15, 2023 |
| 18468639 | METHOD FOR DETECTING NEUROLOGICAL DISEASES USING SUPRAMOLECULE POLYMER THERAPEUTICS | The Regents of the University of California | ESSEX, LAURA ANN | 1675 | Non-Final OA | Sep 15, 2023 |
| 18468633 | SUPRAMOLECULAR POLYMER THERAPEUTICS AND DIAGNOSTICS | The Regents of the University of California | ESSEX, LAURA ANN | 1675 | Non-Final OA | Sep 15, 2023 |
| 18279377 | 7-Morpholino-L,6-Naphthyridin-5-yl Derivatives and Pharmaceutical Compositions Thereof Useful as DNA-PK Inhibitor | Provincial Health Services Authority | WILLIS, DOUGLAS M | 1624 | Non-Final OA | Aug 29, 2023 |
| 18279379 | 7-Morpholino-1,6-Naphthyridin-5-yl Derivatives and Pharmaceutical Compositions Thereof Useful as DNA-PK Inhibitor | Provincial Health Services Authority | NEAGU, IRINA | 1629 | Non-Final OA | Aug 29, 2023 |
| 18278377 | CONDITIONAL DEGRADATION OF PROTEINS THAT ARE LOCALIZED AT THE PLASMA MEMBRANE | The Regents of the University of California | NICKOL, GARY B | 1643 | Non-Final OA | Aug 22, 2023 |
| 18547139 | Oncolytic Virus and Methods of Use | NorthShore University HealthSystem | WANG, RUIXUE | 1672 | Non-Final OA | Aug 18, 2023 |
| 18276834 | Endometriosis-Related Methods and Compositions | The Regents of the University of California | AL-AWADI, DANAH J | 1615 | Non-Final OA | Aug 10, 2023 |
| 18275170 | Methods for Pulmonary Function Testing With Machine Learning Analysis and Systems for Same | The Regents of the University of California | HANEY, JONATHAN MICHAEL | 3791 | Non-Final OA | Jul 31, 2023 |
| 18361516 | Activatable Membrane-Interacting Peptides and Methods of Use | The Regents of the University of California | LEE, JIA-HAI | 1658 | Non-Final OA | Jul 28, 2023 |
| 18274152 | Genetically Modified Hepatocyte Populations | Cytotheryx, Inc. | STEIN, LEAH ELIZABETH | 1641 | Non-Final OA | Jul 25, 2023 |
| 18223943 | Drug Implants Containing Darolutamide and Methods of Use Thereof | Alessa Therapeutics, Inc. | WERTZ, ASHLEE ELIZABETH | 1612 | Non-Final OA | Jul 19, 2023 |
| 18351367 | Autoantigens Engineered to Suppress Autoimmune Response | Adaxion Therapeutics, Inc. | REN, HONG | 1647 | Non-Final OA | Jul 12, 2023 |
| 18268957 | PREPARATION AND APPLICATION METHOD OF HETEROCYCLIC COMPOUNDS AS KRAS INHIBITOR | Shanghai Kechow Pharma, Inc. | VISHNYAKOVA, ELENA VLADIMIROVNA | 1691 | Final Rejection | Jun 21, 2023 |
| 18267732 | Method for Evaluating Adapter Ligation Efficiency in Sequencing of DNA Sample | Genodive Pharma Inc. | SALMON, KATHERINE D | 1682 | Non-Final OA | Jun 15, 2023 |
| 18208576 | METHOD AND APPARATUS FOR REDUCING PROBABILITY OF ICE NUCLEATION DURING PRESERVATION OF BIOLOGICAL MATTER IN ISOCHORIC SYSTEMS | Biochoric, Inc. | MCCORMICK, CATHERINE LYNN | 1638 | Non-Final OA | Jun 12, 2023 |
| 18265410 | Plants With Sr2-mediated Stem Rust Resistance | Grains Research And Development Corporation | ORDAZ, CHRISTIAN JOSE | 1663 | Non-Final OA | Jun 05, 2023 |
| 18205215 | RNA VIRUS INHIBITOR COMPOUNDS WITH IMPROVED METABOLIC STABILITY AND USES THEREOF | The Governors of the University of Alberta | KUCKLA, ANNA GRACE | 1626 | Non-Final OA | Jun 02, 2023 |
| 18039840 | Antibody Delivery | Ac Immune SA | MCCORMICK, CATHERINE LYNN | 1638 | Non-Final OA | Jun 01, 2023 |
| 18039126 | METHODS FOR USING NEUROTROPHIN RECEPTOR BINDING CONJUGATE COMPOSITIONS IN THE TREATMENT OF A NEUROLOGICAL CONDITION | Manzanita Pharmaceuticals, Inc. | MIKNIS, ZACHARY J | 1658 | Non-Final OA | May 26, 2023 |
| 18201911 | T-CELL MODULATORY MULTIMERIC POLYPEPTIDES AND METHODS OF USE THEREOF | Cue Biopharma, Inc. | CUNNINGCHEN, KATHLEEN MARY | 1646 | Non-Final OA | May 25, 2023 |
| 18036133 | CLUBROOT RESISTANCE IN RAPESEED BRASSICA NAPUS | Npz Innovation GmbH | WILLIAMS, KEITH RICHARD | 1663 | Non-Final OA | May 09, 2023 |
| 18034045 | CONTROLLING CELLULAR BEHAVIOR USING FEED-FORWARD CIRCUITS | The Regents of the University of California | NICOL, ALEXANDER W | 1634 | Non-Final OA | Apr 26, 2023 |
| 18032101 | CORONA VIRUS-SPECIFIC T CELL RECEPTOR FUSION CONSTRUCTS, VECTORS ENCODING THE SAME, T CELLS COMPRISING THE SAME AND USES THEREOF | Albert-Ludwigs-Universität Freiburg | AEDER, SEAN E | 1642 | Non-Final OA | Apr 14, 2023 |
| 18193443 | PROTEINS FOR MODULATING CELL THERAPY PRODUCTS AND METHODS OF USE THEREOF | Cue Biopharma, Inc. | LOCKARD, JON MCCLELLAND | 1647 | Non-Final OA | Mar 30, 2023 |
| 18028883 | METHOD OF PRODUCING A RECOMBINANT PROTEIN IN A HOST CELL WHICH HAS A DISABLED RHAMNOSE METABOLISM AS WELL AS EXPRESSION VECTORS, HOST CELLS AND RECOMBINANT PROTEINS THEREOF | Xbrane Biopharma AB | HOLLAND, PAUL J | 1656 | Non-Final OA | Mar 28, 2023 |
| 18043675 | ANTI ABCC1 ANTIBODIES AND USES THEREOF | William Robert Arathoon Living Trust Dated August 29, 2016 | LEE, YIE CHIA | 1642 | Non-Final OA | Mar 01, 2023 |
| 18020593 | Humanized Anti-TDP-43 Binding Molecules and Uses Thereof | Ac Immune SA | HADDAD, MAHER M | 1641 | Non-Final OA | Feb 09, 2023 |
| 18020611 | TARGETED PROTEIN DEGRADATION IN THERAPEUTIC CELLS | The Regents of the University of California | BELYAVSKYI, MICHAIL A | 1644 | Non-Final OA | Feb 09, 2023 |
| 18107265 | MHC CLASS II T-CELL MODULATORY MULTIMERIC POLYPEPTIDES AND METHODS OF USE THEREOF | Cue Biopharma, Inc. | HUYNH, PHUONG N | 1641 | Non-Final OA | Feb 08, 2023 |
| 18107244 | MHC CLASS II T-CELL MODULATORY MULTIMERIC POLYPEPTIDES FOR TREATING TYPE 1 DIABETES MELLITUS (T1D) AND METHODS OF USE THEREOF | Cue Biopharma, Inc. | DIBRINO, MARIANNE | 1641 | Non-Final OA | Feb 08, 2023 |
| 18103809 | ANTIGEN-PRESENTING POLYPEPTIDES AND METHODS OF USE THEREOF | Cue Biopharma, Inc. | SKELDING, ZACHARY S | 1644 | Non-Final OA | Jan 31, 2023 |
| 18017849 | COMBINATORIAL ANTIGEN RECOGNITION IN CANCER T CELL THERAPIES | The Simons Foundation, Inc. | PETERS, ALEC JON | 1641 | Non-Final OA | Jan 24, 2023 |
| 18158396 | GENE EXPRESSION PROFILES TO PREDICT BREAST CANCER OUTCOMES | British Columbia Cancer Agency Branch | YU, TIAN NMN | 1681 | Final Rejection | Jan 23, 2023 |
| 18015510 | Methods For Detecting Biomolecules of Interest By Biolayer Interferometry | The Regents of the University of California | OGUNTADE, ELIZABETH BISOLA | 1677 | Non-Final OA | Jan 10, 2023 |
| 18069124 | Binding Proteins 2 | Yale University | DUTT, ADITI | 1675 | Non-Final OA | Dec 20, 2022 |
| 18002385 | Chlorite In the Treatment of Acute Respiratory Distress Syndrome | The Regents of the University of California | NGUYEN, NGOC-ANH THI | 1615 | Final Rejection | Dec 19, 2022 |
| 18010188 | Selective Addition of Reagents to Droplets | The Regents of the University of California | KENNEDY, SARAH JANE | 1682 | Final Rejection | Dec 13, 2022 |
| 18064196 | Barcoded Solid Supports and Methods of Making and Using Same | The Regents of the University of California | WILDER, CYNTHIA B | 1681 | Non-Final OA | Dec 09, 2022 |
| 18009688 | USE OF PHYTOCANNABINOIDS FOR TREATING MULTIPLE MYELOMA | Entourage Biosciences Inc. | HAVLIN, ROBERT H | 1626 | Final Rejection | Dec 09, 2022 |
| 17993506 | PHARMACEUTICAL PREPARATION AND PREPARATION METHOD THEREFOR | Xizang Haisco Pharmaceutical Co., Ltd. | TIEN, LUCY MINYU | 1612 | Final Rejection | Nov 23, 2022 |
| 17926921 | System for Localization of Anatomical Sites | The Regents of the University of California | POPESCU, GABRIEL VICTOR | 3797 | Final Rejection | Nov 21, 2022 |
| 17998841 | ABCG2 EFFLUX PUMP-CANCER ANTIGEN MULTI-SPECIFIC ANTIBODIES AND COMPOSITIONS, REAGENTS, KITS AND METHODS RELATED THERETO | William Robert Arathoon Living Trust Dated August 29, 2016 | MOSELEY II, NELSON B | 1642 | Non-Final OA | Nov 15, 2022 |
| 17998773 | ANTI-ABCG2 ANTIBODIES AND USES THEREOF | William Robert Arathoon Living Trust Dated August 29, 2016 | DARPOLOR, JOSEPHINE KEBBEH | 1642 | Non-Final OA | Nov 14, 2022 |
| 17998641 | METHODS AND ANTIBODIES IN TREATMENT OF FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS) | The Regents of the University of California | SHUPE, ELIZABETH A | 1643 | Final Rejection | Nov 11, 2022 |
| 17995083 | Genetically Engineered Phagocytes, and Related Compositions, Vectors, Methods and Systems | The Regents of the University of California | AMICK, THOMAS RUSSE | 1638 | Non-Final OA | Sep 29, 2022 |
| 17995058 | Methods, Compositions, and Kits for Identifying Regions of Genomic DNA Bound to a Protein | The Brigham And Women'S Hospital, Inc. | VANN-OJUEKAIYE, KENDRA RAYCHELL | 1682 | Final Rejection | Sep 29, 2022 |
| 17913540 | Compositions and Methods for Treatment | The Regents of the University of California | GRABER, JAMES J | 1631 | Non-Final OA | Sep 22, 2022 |
| 17912382 | Method for Estimating Molecular Complexity | The University Court of the University of Glasgow | XU, XIAOYUN | 1797 | Non-Final OA | Sep 16, 2022 |
| 17944855 | METHODS FOR GENETIC IDENTIFICATION AND RELATEDNESS DETECTION | The Regents of the University of California | CRAWLEY, TALIA F | 3627 | Non-Final OA | Sep 14, 2022 |
| 17822584 | T CELL MODULATORY POLYPEPTIDES AND METHODS OF USE THEREOF | Cue Biopharma, Inc. | BLUMEL, BENJAMIN P | 1671 | Non-Final OA | Aug 26, 2022 |
| 17904565 | Adeno-Associated Viral (AAV)-Mediated Sgpl1 Gene Therapy For Treatment Of Sphingosine-1-Phosphate Lyase Insufficiency Syndrome (SPLIS) | The Regents of the University of California | PENNINGTON, KATIE LEIGH | 1634 | Final Rejection | Aug 18, 2022 |
| 17800872 | IN-SERIES SYNTHETIC RECEPTOR AND-GATE CIRCUITS FOR EXPRESSION OF A THERAPEUTIC PAYLOAD BY ENGINEERED CELLS | The Regents of the University of California | HILL, KEVIN KAI | 1638 | Non-Final OA | Aug 18, 2022 |
| 17800516 | Inhibitors of Human Herpesviruses | The Governors of the University of Alberta | ENGLISH, CONNOR KENNEDY | 1625 | Final Rejection | Aug 17, 2022 |
| 17887199 | T-CELL MODULATORY MULTIMERIC POLYPEPTIDES AND METHODS OF USE THEREOF | Cue Biopharma, Inc. | DIBRINO, MARIANNE | 1641 | Non-Final OA | Aug 12, 2022 |
| 17794750 | DETECTING GUT BARRIER DYSFUNCTION AND/OR CIRRHOSIS | Macfarlane Burnet Institute For Medical Research And Public Health Limited | LUSI, ELLIS FOLLETT | 1677 | Final Rejection | Jul 22, 2022 |
| 17863153 | Antifouling Polymeric Coating Compositions | The University of British Columbia | PIPIC, ALMA | 1617 | Non-Final OA | Jul 12, 2022 |
| 17788179 | Methods for Treating Inflammatory Bowel Diseases with alpha4beta7 Integrin Antagonists | Protagonist Therapeutics, Inc. | BEANE, RANDALL L | 1654 | Non-Final OA | Jun 22, 2022 |
| 17782536 | Novel Molecules for Therapy and Diagnosis | Ac Immune SA | TAYLOR, LIA ELAN | 1641 | Non-Final OA | Jun 03, 2022 |
| 17781297 | Treatment or Prevention of Ischaemic Stroke Reperfusion Injury | Cambridge Enterprise Limited | NEAGU, IRINA | 1629 | Non-Final OA | May 31, 2022 |
| 17745399 | NANOPORE SENSOR FOR ENZYME-MEDIATED PROTEIN TRANSLOCATION | The Regents of the University of California | MINCHELLA, KAITLYN L | 1685 | Non-Final OA | May 16, 2022 |
| 17773404 | MrgprX2 Antagonists and Uses Thereof | Dermira, Inc. | ENGLISH, CONNOR KENNEDY | 1625 | Non-Final OA | Apr 29, 2022 |
| 17773414 | MrgprX2 Antagonists and Uses Thereof | Dermira, Inc. | HEITMEIER, KENDALL NICOLE | 1621 | Final Rejection | Apr 29, 2022 |
| 17772467 | MrgprX2 Antagonists for the Treatment of Inflammatory Disorders | Dermira, Inc. | WELLS, LAUREN QUINLAN | 1622 | Non-Final OA | Apr 27, 2022 |
| 17769693 | NEUROTROPHIN RECEPTOR BINDING CONJUGATE COMPOSITIONS, METHODS OF USE AND METHODS OF MAKING THEREOF | Manzanita Pharmaceuticals, Inc. | SCHLIENTZ, LEAH H | 1618 | Final Rejection | Apr 15, 2022 |
| 17641935 | IMMUNE CELL SEQUENCING METHODS | The Regents of the University of California | CHUNDURU, SURYAPRABHA | 1681 | Final Rejection | Mar 10, 2022 |
| 17640656 | Novel Molecules for Diagnosis | Ac Immune SA | BALLARD, KIMBERLY | 1675 | Non-Final OA | Mar 04, 2022 |
| 17633749 | Neurofeedback Training to Promote Sharp Wave Ripples | The Regents of the University of California | ORTEGA, MARTIN NATHAN | 3791 | Non-Final OA | Feb 08, 2022 |
| 17630875 | SYNTHETIC IMMUNE CELLS AND METHODS OF USE THEREOF | The Regents of the University of California | RYAN, DOUGLAS CHARLES | 1635 | Non-Final OA | Jan 27, 2022 |
| 17629295 | CD63 AGONIST-RELATED METHODS AND COMPOSITIONS | AgonOx, Inc. | HOPKINS, SAMANTHA LAKE | 1641 | Non-Final OA | Jan 21, 2022 |
| 17544527 | Screening for Inhibitors of Prostaglandin E Synthase 3 Useful for Treatment of Prostate Cancer | The Regents of the University of California | RYAN, DOUGLAS CHARLES | 1635 | Final Rejection | Dec 07, 2021 |
| 17490516 | MULTIMERIC T-CELL MODULATORY POLYPEPTIDES AND METHODS OF USE THEREOF | Cue Biopharma, Inc. | PATTERSON, SARAH COOPER | 1675 | Final Rejection | Sep 30, 2021 |
| 17441575 | METHODS AND APPARATUSES FOR PRODUCING SOLID DRY MANURE | The Regents of the University of California | LAU, JASON | 3762 | Non-Final OA | Sep 21, 2021 |
| 17470523 | COMBINED MULTIPLE-DISPLACEMENT AMPLIFICATION AND PCR IN AN EMULSION MICRODROPLET | The Regents of the University of California | GIAMMONA, FRANCESCA FILIPPA | 1681 | Non-Final OA | Sep 09, 2021 |
| 17436041 | COMPOSITIONS COMPRISING ENZYME-CLEAVABLE AMPHETAMINE PRODRUGS AND INHIBITORS THEREOF | Ensysce Biosciences, Inc. | BEANE, RANDALL L | 1654 | Final Rejection | Sep 02, 2021 |
| 17459160 | Vibratory Expulsive Therapy For Urinary Stones | The Regents of the University of California | LEDERER, SARAH B | 3785 | Non-Final OA | Aug 27, 2021 |
| 17297728 | Rust Resistance Gene | Commonwealth Scientific And Industrial Research Organisation | SHARMA, SANTOSH | 1663 | Final Rejection | May 27, 2021 |
| 17278628 | ANTIGEN DENSITY SENSING MOLECULAR CIRCUITS AND METHODS OF USE THEREOF | The Regents of the University of California | PENNINGTON, KATIE LEIGH | 1634 | Non-Final OA | Mar 22, 2021 |
| 17275110 | Artificial Periosteum | Orthocell Limited | MARTINEZ, TARA L | 1654 | Non-Final OA | Mar 10, 2021 |
| 17273065 | High-Throughput Screening Platform for Longevity Genes and Anti-Aging Drugs | The Regents of the University of California | PERSONS, JENNA L | 1637 | Final Rejection | Mar 03, 2021 |
| 17266911 | Monodispersed Particle-Triggered Droplet Formation from Stable Jets | The Regents of the University of California | THOMPSON, CURTIS A | 1798 | Final Rejection | Feb 08, 2021 |
| 17059481 | Methods and compositions for targeting Tregs using CCR8 inhibitors | Nanjing Immunophage Biomedical Co., Ltd. | SHTERENGARTS, SAMANTHA L | 1623 | Non-Final OA | Nov 30, 2020 |
| 16983810 | PANCREATIC ENDOCRINE PROGENITOR CELL THERAPIES FOR THE TREATMENT OF OBESITY AND TYPE 2 DIABETES (T2D) | Ccs Ventures Limited | REGLAS, GEORGIANA C | 1651 | Final Rejection | Aug 03, 2020 |
| 16749923 | Method for Detecting Tumor DNA in a cfDNA Sample Collected from a Patient that has Previously Undergone Cancer Therapy | Cancer Research Technology Limited | WOITACH, JOSEPH T | 1687 | Non-Final OA | Jan 22, 2020 |
| 15577681 | Methods and Systems for Treating Neurological Movement Disorders | The Regents of the University of California | BERHANU, ETSUB D | 3791 | Final Rejection | Nov 28, 2017 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial